About Hainan Poly Pharm Co., Ltd.
Hainan Poly Pharm Co., Ltd., founded in 1992 and based in the Guilinyang Economic Development Area of Haikou, Hainan, is a listed Chinese pharmaceutical manufacturer (SZSE: 300630) specialising in internationally standardised generic medicines and incremental innovation. It is one of the few Chinese companies with established registrations in the regulated markets of Europe and the United States.
Its speciality is injectable formulations —including prefilled syringes and lyophilised products—, oral solid forms such as tablets, capsules and granules, and active pharmaceutical ingredient (API) production. It masters controlled-release, taste-masking and insoluble-drug injection technologies, which it applies across its complex generics portfolio.
Poly Pharm combines plants in Hainan and Zhejiang with a product-by-product international registration strategy. For pharmaceutical distributors, it represents a Chinese supplier of generic injectables with demonstrable experience before Western regulatory agencies.
Its speciality is injectable formulations —including prefilled syringes and lyophilised products—, oral solid forms such as tablets, capsules and granules, and active pharmaceutical ingredient (API) production. It masters controlled-release, taste-masking and insoluble-drug injection technologies, which it applies across its complex generics portfolio.
Poly Pharm combines plants in Hainan and Zhejiang with a product-by-product international registration strategy. For pharmaceutical distributors, it represents a Chinese supplier of generic injectables with demonstrable experience before Western regulatory agencies.